ZOE ORECK

Lobbying with regard to the implementation of the SMART Act (Public Law 112-242), generally. Lobbying with regard to the Medicare Secondary Payer Program, generally. S. 1514/H.R. 2649 (Medicare Secondary Payer and Workers' Compensation Settlement Agreements Act of 2015); provides for the application of Medicare secondary payer rules to certain workers' compensation settlement agreements and qualified Medicare set-aside provisions. Lobbying with regard to the Medicaid Third Party Liability Program, generally. S. 884/H.R. 836 (Health Care Safety Net Enhancement Act of 2015); improves access to emergency medical services, and for other purposes. H.R. 1021 (Protecting the Integrity of Medicare Act); amends Title XVIII of the Social Security Act to improve the integrity of the Medicare program, and for other purposes. H.R. 1376 (Patient Choice Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to authorize provisional approval of fast-track products determined by the Secretary of Health and Human Services (HHS) to be adequately safe. H.R. 2300 (Empowering Patients First Act of 2015); provides for incentives to encourage health insurance coverage. H.R. 2653 (American Health Care Reform Act of 2015); repeals the Patient Protection and Affordable Care Act and related reconciliation provisions, to promote patient-centered health care, to provide for the creation of a safe harbor for defendants in medical malpractice actions who demonstrate adherence to clinical practice guidelines. S. 2204 (End of Suffering Act of 2015); respects the Constitutional entitlement to liberty by recognizing the right of an individual to have personal control over the medical assistance and treatment necessary to avoid intolerable physical suffering. H.R.__/S.__ (Behavioral Health Information Technology Act); draft legislation amending the Public Health Service Act to include as a health care provider behavioral and mental health professionals, substance abuse professionals, psychiatric hospitals, certain community mental health centers (including one operated by a county behavioral health agency), and residential or outpatient mental health or substance abuse treatment facilities. H.R. 5403 (Ariel Grace's Law); to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices. S. 2912 (Trickett Wendler Right to Try Act of 2016); to authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes. H.R. 6 (21st Century Cures Act); establishing and appropriating funds, and reforming Medicaid, Medicare, and other reforms.

Lobbying with regard to the implementation of the SMART Act (Public Law 112-242), generally. Lobbying with regard to the Medicare Secondary Payer Program, generally. Lobbying with regard to the Medicare Third Party Liability Program, generally. S. 884/H.R. 836 (Health Care Safety Net Enhancement Act of 2015); improves access to emergency medical services, and for other purposes. H.R. 1021 (Protecting the Integrity of Medicare Act); amends Title XVIII of the Social Security Act to improve the integrity of the Medicare program, and for other purposes. H.R. 1376 (Patient Choice Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to authorize provisional approval of fast-track products determined by the Secretary of Health and Human Services (HHS) to be adequately safe. H.R. 2300 (Empowering Patients First Act of 2015); provides for incentives to encourage health insurance coverage. H.R. 2653 (American Health Care Reform Act of 2015); repeals the Patient Protection and Affordable Care Act and related reconciliation provisions, to promote patient-centered health care, to provide for the creation of a safe harbor for defendants in medical malpractice actions who demonstrate adherence to clinical practice guidelines. S. 2204 (End of Suffering Act of 2015); respects the Constitutional entitlement to liberty by recognizing the right of an individual to have personal control over the medical assistance and treatment necessary to avoid intolerable physical suffering. H.R.__/S.__ (Behavioral Health Information Technology Act); draft legislation amending the Public Health Service Act to include as a health care provider behavioral and mental health professionals, substance abuse professionals, psychiatric hospitals, certain community mental health centers (including one operated by a county behavioral health agency), and residential or outpatient mental health or substance abuse treatment facilities.

Lobbying with regard to the implementation of the SMART Act (Public Law 112-242), generally. Lobbying with regard to the Medicare Secondary Payer Program, generally. S. 1514/H.R. 2649 (Medicare Secondary Payer and Workers' Compensation Settlement Agreements Act of 2015); provides for the application of Medicare secondary payer rules to certain workers' compensation settlement agreements and qualified Medicare set-aside provisions. Lobbying with regard to the Medicaid Third Party Liability Program, generally. S. 884/H.R. 836 (Health Care Safety Net Enhancement Act of 2015); improves access to emergency medical services, and for other purposes. H.R. 1021 (Protecting the Integrity of Medicare Act); amends Title XVIII of the Social Security Act to improve the integrity of the Medicare program, and for other purposes. H.R. 1376 (Patient Choice Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to authorize provisional approval of fast-track products determined by the Secretary of Health and Human Services (HHS) to be adequately safe. H.R. 2300 (Empowering Patients First Act of 2015); provides for incentives to encourage health insurance coverage. H.R. 2653 (American Health Care Reform Act of 2015); repeals the Patient Protection and Affordable Care Act and related reconciliation provisions, to promote patient-centered health care, to provide for the creation of a safe harbor for defendants in medical malpractice actions who demonstrate adherence to clinical practice guidelines. S. 2204 (End of Suffering Act of 2015); respects the Constitutional entitlement to liberty by recognizing the right of an individual to have personal control over the medical assistance and treatment necessary to avoid intolerable physical suffering. H.R.__/S.__ (Behavioral Health Information Technology Act); draft legislation amending the Public Health Service Act to include as a health care provider behavioral and mental health professionals, substance abuse professionals, psychiatric hospitals, certain community mental health centers (including one operated by a county behavioral health agency), and residential or outpatient mental health or substance abuse treatment facilities. H.R. 5403 (Ariel Grace's Law); to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices. S. 2912 (Trickett Wendler Right to Try Act of 2016); to authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes. H.R. 6 (21st Century Cures Act); establishing and appropriating funds, and reforming Medicaid, Medicare, and other reforms. General lobbying with regard to pharmaceutical price-gouging. H.R. 6120 (Secondary Payer Advancement, Rationalization, and Clarification (SPARC) Act); amends title XVIII of the Social Security Act to provide for clarification and rationalization of Medicare prescription drug plan recovery rules for certain claims.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. S. 3446/H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period. General lobbying with respect to diversity jurisdiction and potential changes to the jurisdiction rules. S. 3155/H.R. 889 (Foreign Cultural Exchange Jurisdictional Immunity Clarification Act); to amend chapter 97 of title 28, United States Code, to clarify the exception to foreign sovereign immunity set forth in section 1605(a)(3) of such title) S. 2763/H.R. 6130 (Holocaust Expropriated Art Recovery Act of 2016); to provide the victims of Holocaust-era persecution and their heirs a fair opportunity to recover works of art confiscated or misappropriated by the Nazis.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. General lobbying with regard to altering the requirement of complete diversity. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. General lobbying with regard to regulatory reform issues. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. S. 3446/H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period. General lobbying with respect to diversity jurisdiction and potential changes to the jurisdiction rules. S. 3155/H.R. 889 (Foreign Cultural Exchange Jurisdictional Immunity Clarification Act); to amend chapter 97 of title 28, United States Code, to clarify the exception to foreign sovereign immunity set forth in section 1605(a)(3) of such title) S. 2763/H.R. 6130 (Holocaust Expropriated Art Recovery Act of 2016); to provide the victims of Holocaust-era persecution and their heirs a fair opportunity to recover works of art confiscated or misappropriated by the Nazis.

H.R. 2647 (Resilient Federal Forests Act of 2015); expedites under the National Environmental Policy Act of 1969 and improve forest management activities on National Forest System lands, on public lands under the jurisdiction of the Bureau of Land Management, and on tribal lands to return resilience to overgrown, fire-prone forested lands. S. 544/H.R. 1040 (Secret Science Reform Act of 2015); prohibits the Environmental Protection Agency from proposing, finalizing, or disseminating regulations or assessments based upon science that is not transparent or reproducible. H.R. 8 (North American Energy Security and Infrastructure Act); modernizes energy infrastructure. S. 3085 (Emergency Wildfire and Forest Management Act of 2016); to improve forest management activities on National Forest System land and public land, and for other purposes.

H.R. 2647 (Resilient Federal Forests Act of 2015); expedites under the National Environmental Policy Act of 1969 and improve forest management activities on National Forest System lands, on public lands under the jurisdiction of the Bureau of Land Management, and on tribal lands to return resilience to overgrown, fire-prone forested lands. S. 544/H.R. 1040 (Secret Science Reform Act of 2015); prohibits the Environmental Protection Agency from proposing, finalizing, or disseminating regulations or assessments based upon science that is not transparent or reproducible. H.R. 8 (North American Energy Security and Infrastructure Act); modernizes energy infrastructure. S. 3085 (Emergency Wildfire and Forest Management Act of 2016); to improve forest management activities on National Forest System land and public land, and for other purposes.

H.R. 2647 (Resilient Federal Forests Act of 2015); expedites under the National Environmental Policy Act of 1969 and improve forest management activities on National Forest System lands, on public lands under the jurisdiction of the Bureau of Land Management, and on tribal lands to return resilience to overgrown, fire-prone forested lands. S. 544/H.R. 1040 (Secret Science Reform Act of 2015); prohibits the Environmental Protection Agency from proposing, finalizing, or disseminating regulations or assessments based upon science that is not transparent or reproducible. H.R. 8 (North American Energy Security and Infrastructure Act); modernizes energy infrastructure.

H.R. 2647 (Resilient Federal Forests Act of 2015); expedites under the National Environmental Policy Act of 1969 and improve forest management activities on National Forest System lands, on public lands under the jurisdiction of the Bureau of Land Management, and on tribal lands to return resilience to overgrown, fire-prone forested lands. S. 544/H.R. 1040 (Secret Science Reform Act of 2015); prohibits the Environmental Protection Agency from proposing, finalizing, or disseminating regulations or assessments based upon science that is not transparent or reproducible. H.R. 8 (North American Energy Security and Infrastructure Act); modernizes energy infrastructure.

H.R. 1098 (Investor Choice Act of 2015); amends the Securities Exchange Act of 1934 and the Investment Advisers Act of 1940 to revise the authority of the Securities and Exchange Commission (SEC) to prohibit, or impose conditions or limitations on the use of agreements that require customers or clients of any broker, dealer, or municipal securities dealer to arbitrate any future dispute between then arising under the federal securities laws, related rules and regulations, or the rules of a self-regulatory organization if it finds that prohibition, imposition of conditions, or limitations are in the public interest and for the protection of investors. H.R. 1266 (Financial Product Safety Commission Act of 2015); Amends the Consumer Financial Protection Act of 2010 to replace the Consumer Financial Protection Bureau as an independent bureau within the Federal Reserve System, with an independent Financial Product Safety Commission that is to regulate the offering and provision of consumer financial products or services. H.R. 957 (CFPB-IG Act of 2015); Requires Senate confirmation of Inspector General of the Bureau of Consumer Financial Protection. H.R. 1090 (Retail Investor Protection Act); Prohibits the Secretary of Labor from prescribing any regulation under the Employee Retirement Income Security Act of 1974 (ERISA) defining the circumstances under which an individual is considered a fiduciary until 60 days after the Securities and Exchange Commission (SEC) issues a final rule governing standards of conduct for brokers and dealers under specified law. Lobbying with regard to rulemaking affecting fiduciary responsibilities of retirement advisors. H.J.Res. 88; disapproving the rule submitted by the Department of Labor relating to the definition of the term Fiduciary." S.J.Res. 33; providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to the definition of the term fiduciary and the conflict of interest rule with respect to retirement investment advice. H.R. 4293 (Affordable Retirement Advice Protection Act); amends ERISA to impose a new best interest standard, requires a rulemaking to be approved by Congress. H.R. 4294 (SAVERS Act); amends the Internal Revenue Code to exempt from the tax on prohibited transactions: (1) the provision of investment advice by a fiduciary to a pension plan, plan participant, or beneficiary which is a best interest recommendation; and (2) any transaction, including a contract for service, between an investment provider and the advice recipient if no more than reasonable compensation is paid for such investment advice and certain disclosures are made with respect to the cost of such advice. S. 2216/H.R. 4538 (Senior$afe Act of 2015); provides immunity from suit for certain individuals who disclose potential examples of financial exploitation of senior citizens.

H.R. 1098 (Investor Choice Act of 2015); amends the Securities Exchange Act of 1934 and the Investment Advisers Act of 1940 to revise the authority of the Securities and Exchange Commission (SEC) to prohibit, or impose conditions or limitations on the use of agreements that require customers or clients of any broker, dealer, or municipal securities dealer to arbitrate any future dispute between then arising under the federal securities laws, related rules and regulations, or the rules of a self-regulatory organization if it finds that prohibition, imposition of conditions, or limitations are in the public interest and for the protection of investors. H.R. 1266 (Financial Product Safety Commission Act of 2015); Amends the Consumer Financial Protection Act of 2010 to replace the Consumer Financial Protection Bureau as an independent bureau within the Federal Reserve System, with an independent Financial Product Safety Commission that is to regulate the offering and provision of consumer financial products or services. H.R. 957 (CFPB-IG Act of 2015); Requires Senate confirmation of Inspector General of the Bureau of Consumer Financial Protection. H.R. 1090 (Retail Investor Protection Act); Prohibits the Secretary of Labor from prescribing any regulation under the Employee Retirement Income Security Act of 1974 (ERISA) defining the circumstances under which an individual is considered a fiduciary until 60 days after the Securities and Exchange Commission (SEC) issues a final rule governing standards of conduct for brokers and dealers under specified law. Lobbying with regard to rulemaking affecting fiduciary responsibilities of retirement advisors. H.R. 4293 (Affordable Retirement Advice Protection Act); amends ERISA to impose a new best interest standard, requires a rulemaking to be approved by Congress. H.R. 4294 (SAVERS Act); amends the Internal Revenue Code to exempt from the tax on prohibited transactions: (1) the provision of investment advice by a fiduciary to a pension plan, plan participant, or beneficiary which is a best interest recommendation; and (2) any transaction, including a contract for service, between an investment provider and the advice recipient if no more than reasonable compensation is paid for such investment advice and certain disclosures are made with respect to the cost of such advice.

H.R. 1098 (Investor Choice Act of 2015); amends the Securities Exchange Act of 1934 and the Investment Advisers Act of 1940 to revise the authority of the Securities and Exchange Commission (SEC) to prohibit, or impose conditions or limitations on the use of agreements that require customers or clients of any broker, dealer, or municipal securities dealer to arbitrate any future dispute between then arising under the federal securities laws, related rules and regulations, or the rules of a self-regulatory organization if it finds that prohibition, imposition of conditions, or limitations are in the public interest and for the protection of investors. H.R. 1266 (Financial Product Safety Commission Act of 2015); Amends the Consumer Financial Protection Act of 2010 to replace the Consumer Financial Protection Bureau as an independent bureau within the Federal Reserve System, with an independent Financial Product Safety Commission that is to regulate the offering and provision of consumer financial products or services. H.R. 957 (CFPB-IG Act of 2015); Requires Senate confirmation of Inspector General of the Bureau of Consumer Financial Protection. H.R. 1090 (Retail Investor Protection Act); Prohibits the Secretary of Labor from prescribing any regulation under the Employee Retirement Income Security Act of 1974 (ERISA) defining the circumstances under which an individual is considered a fiduciary until 60 days after the Securities and Exchange Commission (SEC) issues a final rule governing standards of conduct for brokers and dealers under specified law. Lobbying with regard to rulemaking affecting fiduciary responsibilities of retirement advisors. H.J.Res. 88; disapproving the rule submitted by the Department of Labor relating to the definition of the term Fiduciary." S.J.Res. 33; providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to the definition of the term fiduciary and the conflict of interest rule with respect to retirement investment advice. H.R. 4293 (Affordable Retirement Advice Protection Act); amends ERISA to impose a new best interest standard, requires a rulemaking to be approved by Congress. H.R. 4294 (SAVERS Act); amends the Internal Revenue Code to exempt from the tax on prohibited transactions: (1) the provision of investment advice by a fiduciary to a pension plan, plan participant, or beneficiary which is a best interest recommendation; and (2) any transaction, including a contract for service, between an investment provider and the advice recipient if no more than reasonable compensation is paid for such investment advice and certain disclosures are made with respect to the cost of such advice. S. 2216/H.R. 4538 (Senior$afe Act of 2015); provides immunity from suit for certain individuals who disclose potential examples of financial exploitation of senior citizens.

H.R. 1098 (Investor Choice Act of 2015); amends the Securities Exchange Act of 1934 and the Investment Advisers Act of 1940 to revise the authority of the Securities and Exchange Commission (SEC) to prohibit, or impose conditions or limitations on the use of agreements that require customers or clients of any broker, dealer, or municipal securities dealer to arbitrate any future dispute between then arising under the federal securities laws, related rules and regulations, or the rules of a self-regulatory organization if it finds that prohibition, imposition of conditions, or limitations are in the public interest and for the protection of investors. H.R. 1266 (Financial Product Safety Commission Act of 2015); Amends the Consumer Financial Protection Act of 2010 to replace the Consumer Financial Protection Bureau as an independent bureau within the Federal Reserve System, with an independent Financial Product Safety Commission that is to regulate the offering and provision of consumer financial products or services. H.R. 957 (CFPB-IG Act of 2015); Requires Senate confirmation of Inspector General of the Bureau of Consumer Financial Protection. H.R. 1090 (Retail Investor Protection Act); Prohibits the Secretary of Labor from prescribing any regulation under the Employee Retirement Income Security Act of 1974 (ERISA) defining the circumstances under which an individual is considered a fiduciary until 60 days after the Securities and Exchange Commission (SEC) issues a final rule governing standards of conduct for brokers and dealers under specified law. Lobbying with regard to rulemaking affecting fiduciary responsibilities of retirement advisors. H.J.Res. 88; disapproving the rule submitted by the Department of Labor relating to the definition of the term Fiduciary." S.J.Res. 33; providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to the definition of the term fiduciary and the conflict of interest rule with respect to retirement investment advice. H.R. 4293 (Affordable Retirement Advice Protection Act); amends ERISA to impose a new best interest standard, requires a rulemaking to be approved by Congress. H.R. 4294 (SAVERS Act); amends the Internal Revenue Code to exempt from the tax on prohibited transactions: (1) the provision of investment advice by a fiduciary to a pension plan, plan participant, or beneficiary which is a best interest recommendation; and (2) any transaction, including a contract for service, between an investment provider and the advice recipient if no more than reasonable compensation is paid for such investment advice and certain disclosures are made with respect to the cost of such advice. S. 2216/H.R. 4538 (Senior$afe Act of 2015); provides immunity from suit for certain individuals who disclose potential examples of financial exploitation of senior citizens.

H.R. 1098 (Investor Choice Act of 2015); amends the Securities Exchange Act of 1934 and the Investment Advisers Act of 1940 to revise the authority of the Securities and Exchange Commission (SEC) to prohibit, or impose conditions or limitations on the use of agreements that require customers or clients of any broker, dealer, or municipal securities dealer to arbitrate any future dispute between then arising under the federal securities laws, related rules and regulations, or the rules of a self-regulatory organization if it finds that prohibition, imposition of conditions, or limitations are in the public interest and for the protection of investors. H.R. 1266 (Financial Product Safety Commission Act of 2015); Amends the Consumer Financial Protection Act of 2010 to replace the Consumer Financial Protection Bureau as an independent bureau within the Federal Reserve System, with an independent Financial Product Safety Commission that is to regulate the offering and provision of consumer financial products or services. H.R. 957 (CFPB-IG Act of 2015); Requires Senate confirmation of Inspector General of the Bureau of Consumer Financial Protection. H.R. 1090 (Retail Investor Protection Act); Prohibits the Secretary of Labor from prescribing any regulation under the Employee Retirement Income Security Act of 1974 (ERISA) defining the circumstances under which an individual is considered a fiduciary until 60 days after the Securities and Exchange Commission (SEC) issues a final rule governing standards of conduct for brokers and dealers under specified law. Lobbying with regard to rulemaking affecting fiduciary responsibilities of retirement advisors. H.J.Res. 88; disapproving the rule submitted by the Department of Labor relating to the definition of the term Fiduciary." S.J.Res. 33; providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to the definition of the term fiduciary and the conflict of interest rule with respect to retirement investment advice. H.R. 4293 (Affordable Retirement Advice Protection Act); amends ERISA to impose a new best interest standard, requires a rulemaking to be approved by Congress. H.R. 4294 (SAVERS Act); amends the Internal Revenue Code to exempt from the tax on prohibited transactions: (1) the provision of investment advice by a fiduciary to a pension plan, plan participant, or beneficiary which is a best interest recommendation; and (2) any transaction, including a contract for service, between an investment provider and the advice recipient if no more than reasonable compensation is paid for such investment advice and certain disclosures are made with respect to the cost of such advice. S. 2216/H.R. 4538 (Senior$afe Act of 2015); provides immunity from suit for certain individuals who disclose potential examples of financial exploitation of senior citizens.

H.R. 1098 (Investor Choice Act of 2015); amends the Securities Exchange Act of 1934 and the Investment Advisers Act of 1940 to revise the authority of the Securities and Exchange Commission (SEC) to prohibit, or impose conditions or limitations on the use of agreements that require customers or clients of any broker, dealer, or municipal securities dealer to arbitrate any future dispute between then arising under the federal securities laws, related rules and regulations, or the rules of a self-regulatory organization if it finds that prohibition, imposition of conditions, or limitations are in the public interest and for the protection of investors. H.R. 1266 (Financial Product Safety Commission Act of 2015); Amends the Consumer Financial Protection Act of 2010 to replace the Consumer Financial Protection Bureau as an independent bureau within the Federal Reserve System, with an independent Financial Product Safety Commission that is to regulate the offering and provision of consumer financial products or services. H.R. 957 (CFPB-IG Act of 2015); Requires Senate confirmation of Inspector General of the Bureau of Consumer Financial Protection. H.R. 1090 (Retail Investor Protection Act); Prohibits the Secretary of Labor from prescribing any regulation under the Employee Retirement Income Security Act of 1974 (ERISA) defining the circumstances under which an individual is considered a fiduciary until 60 days after the Securities and Exchange Commission (SEC) issues a final rule governing standards of conduct for brokers and dealers under specified law. Lobbying with regard to rulemaking affecting fiduciary responsibilities of retirement advisors. H.J.Res. 88; disapproving the rule submitted by the Department of Labor relating to the definition of the term Fiduciary." S.J.Res. 33; providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to the definition of the term fiduciary and the conflict of interest rule with respect to retirement investment advice. H.R. 4293 (Affordable Retirement Advice Protection Act); amends ERISA to impose a new best interest standard, requires a rulemaking to be approved by Congress. H.R. 4294 (SAVERS Act); amends the Internal Revenue Code to exempt from the tax on prohibited transactions: (1) the provision of investment advice by a fiduciary to a pension plan, plan participant, or beneficiary which is a best interest recommendation; and (2) any transaction, including a contract for service, between an investment provider and the advice recipient if no more than reasonable compensation is paid for such investment advice and certain disclosures are made with respect to the cost of such advice. S. 2216/H.R. 4538 (Senior$afe Act of 2015); provides immunity from suit for certain individuals who disclose potential examples of financial exploitation of senior citizens.

H.R. 1098 (Investor Choice Act of 2015); amends the Securities Exchange Act of 1934 and the Investment Advisers Act of 1940 to revise the authority of the Securities and Exchange Commission (SEC) to prohibit, or impose conditions or limitations on the use of agreements that require customers or clients of any broker, dealer, or municipal securities dealer to arbitrate any future dispute between then arising under the federal securities laws, related rules and regulations, or the rules of a self-regulatory organization if it finds that prohibition, imposition of conditions, or limitations are in the public interest and for the protection of investors. H.R. 1266 (Financial Product Safety Commission Act of 2015); Amends the Consumer Financial Protection Act of 2010 to replace the Consumer Financial Protection Bureau as an independent bureau within the Federal Reserve System, with an independent Financial Product Safety Commission that is to regulate the offering and provision of consumer financial products or services. H.R. 957 (CFPB-IG Act of 2015); Requires Senate confirmation of Inspector General of the Bureau of Consumer Financial Protection. H.R. 1090 (Retail Investor Protection Act); Prohibits the Secretary of Labor from prescribing any regulation under the Employee Retirement Income Security Act of 1974 (ERISA) defining the circumstances under which an individual is considered a fiduciary until 60 days after the Securities and Exchange Commission (SEC) issues a final rule governing standards of conduct for brokers and dealers under specified law. Lobbying with regard to rulemaking affecting fiduciary responsibilities of retirement advisors. H.R. 4293 (Affordable Retirement Advice Protection Act); amends ERISA to impose a new best interest standard, requires a rulemaking to be approved by Congress. H.R. 4294 (SAVERS Act); amends the Internal Revenue Code to exempt from the tax on prohibited transactions: (1) the provision of investment advice by a fiduciary to a pension plan, plan participant, or beneficiary which is a best interest recommendation; and (2) any transaction, including a contract for service, between an investment provider and the advice recipient if no more than reasonable compensation is paid for such investment advice and certain disclosures are made with respect to the cost of such advice.

H.R. 1098 (Investor Choice Act of 2015); amends the Securities Exchange Act of 1934 and the Investment Advisers Act of 1940 to revise the authority of the Securities and Exchange Commission (SEC) to prohibit, or impose conditions or limitations on the use of agreements that require customers or clients of any broker, dealer, or municipal securities dealer to arbitrate any future dispute between then arising under the federal securities laws, related rules and regulations, or the rules of a self-regulatory organization if it finds that prohibition, imposition of conditions, or limitations are in the public interest and for the protection of investors. H.R. 1266 (Financial Product Safety Commission Act of 2015); Amends the Consumer Financial Protection Act of 2010 to replace the Consumer Financial Protection Bureau as an independent bureau within the Federal Reserve System, with an independent Financial Product Safety Commission that is to regulate the offering and provision of consumer financial products or services. H.R. 957 (CFPB-IG Act of 2015); Requires Senate confirmation of Inspector General of the Bureau of Consumer Financial Protection. H.R. 1090 (Retail Investor Protection Act); Prohibits the Secretary of Labor from prescribing any regulation under the Employee Retirement Income Security Act of 1974 (ERISA) defining the circumstances under which an individual is considered a fiduciary until 60 days after the Securities and Exchange Commission (SEC) issues a final rule governing standards of conduct for brokers and dealers under specified law. Lobbying with regard to rulemaking affecting fiduciary responsibilities of retirement advisors. H.J.Res. 88; disapproving the rule submitted by the Department of Labor relating to the definition of the term Fiduciary." S.J.Res. 33; providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to the definition of the term fiduciary and the conflict of interest rule with respect to retirement investment advice. H.R. 4293 (Affordable Retirement Advice Protection Act); amends ERISA to impose a new best interest standard, requires a rulemaking to be approved by Congress. H.R. 4294 (SAVERS Act); amends the Internal Revenue Code to exempt from the tax on prohibited transactions: (1) the provision of investment advice by a fiduciary to a pension plan, plan participant, or beneficiary which is a best interest recommendation; and (2) any transaction, including a contract for service, between an investment provider and the advice recipient if no more than reasonable compensation is paid for such investment advice and certain disclosures are made with respect to the cost of such advice. S. 2216/H.R. 4538 (Senior$afe Act of 2015); provides immunity from suit for certain individuals who disclose potential examples of financial exploitation of senior citizens.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. S. 3446/H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period. General lobbying with respect to diversity jurisdiction and potential changes to the jurisdiction rules. S. 3155/H.R. 889 (Foreign Cultural Exchange Jurisdictional Immunity Clarification Act); to amend chapter 97 of title 28, United States Code, to clarify the exception to foreign sovereign immunity set forth in section 1605(a)(3) of such title) S. 2763/H.R. 6130 (Holocaust Expropriated Art Recovery Act of 2016); to provide the victims of Holocaust-era persecution and their heirs a fair opportunity to recover works of art confiscated or misappropriated by the Nazis.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. General lobbying with regard to altering the requirement of complete diversity. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. General lobbying with regard to regulatory reform issues. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. S. 3446/H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period. General lobbying with respect to diversity jurisdiction and potential changes to the jurisdiction rules. S. 3155/H.R. 889 (Foreign Cultural Exchange Jurisdictional Immunity Clarification Act); to amend chapter 97 of title 28, United States Code, to clarify the exception to foreign sovereign immunity set forth in section 1605(a)(3) of such title) S. 2763/H.R. 6130 (Holocaust Expropriated Art Recovery Act of 2016); to provide the victims of Holocaust-era persecution and their heirs a fair opportunity to recover works of art confiscated or misappropriated by the Nazis.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 1-01-2017; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. S. 3491/H.R. 6423 (Justice for Victims of Fraud Act of 2016); amends the Truth in Lending Act and the Electronic Fund Transfer Act to prohibit pre-dispute arbitration agreements with consumers (i.e., agreements to arbitrate any future disputes between parties instead of pursuing the claims in court) from being valid or enforceable in disputes related to credit card accounts or personal bank accounts that are not subject to a final judgment by a court if the credit card or bank account was not issued in response to a request or application for that account. General lobbying with regard to the regulation of pre-dispute arbitration by the Federal Communications Commission. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 1-01-2017; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. Lobbying with regard to draft legislation related to PCB exposure and liability. General lobbying with regard to pesticide regulations. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. General lobbying with regard to off-label promotion of pharmaceutical products. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process. H.R. 5983 (Financial CHOICE Act of 2016); repealing provisions of the Dodd-Frank Act.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 10-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 10-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. Lobbying with regard to draft legislation related to PCB exposure and liability. General lobbying with regard to pesticide regulations. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process. H.R. 5983 (Financial CHOICE Act of 2016); repealing provisions of the Dodd-Frank Act.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 04-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 04-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 07-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 07-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 07-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 07-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 10-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 10-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. Lobbying with regard to draft legislation related to PCB exposure and liability. General lobbying with regard to pesticide regulations. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process. H.R. 5983 (Financial CHOICE Act of 2016); repealing provisions of the Dodd-Frank Act.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 04-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 04-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 1-01-2017; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. S. 3491/H.R. 6423 (Justice for Victims of Fraud Act of 2016); amends the Truth in Lending Act and the Electronic Fund Transfer Act to prohibit pre-dispute arbitration agreements with consumers (i.e., agreements to arbitrate any future disputes between parties instead of pursuing the claims in court) from being valid or enforceable in disputes related to credit card accounts or personal bank accounts that are not subject to a final judgment by a court if the credit card or bank account was not issued in response to a request or application for that account. General lobbying with regard to the regulation of pre-dispute arbitration by the Federal Communications Commission. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 1-01-2017; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. Lobbying with regard to draft legislation related to PCB exposure and liability. General lobbying with regard to pesticide regulations. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. General lobbying with regard to off-label promotion of pharmaceutical products. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process. H.R. 5983 (Financial CHOICE Act of 2016); repealing provisions of the Dodd-Frank Act.

H.R. 1098 (Investor Choice Act of 2015); amends the Securities Exchange Act of 1934 and the Investment Advisers Act of 1940 to revise the authority of the Securities and Exchange Commission (SEC) to prohibit, or impose conditions or limitations on the use of agreements that require customers or clients of any broker, dealer, or municipal securities dealer to arbitrate any future dispute between then arising under the federal securities laws, related rules and regulations, or the rules of a self-regulatory organization if it finds that prohibition, imposition of conditions, or limitations are in the public interest and for the protection of investors. H.R. 1266 (Financial Product Safety Commission Act of 2015); Amends the Consumer Financial Protection Act of 2010 to replace the Consumer Financial Protection Bureau as an independent bureau within the Federal Reserve System, with an independent Financial Product Safety Commission that is to regulate the offering and provision of consumer financial products or services. H.R. 957 (CFPB-IG Act of 2015); Requires Senate confirmation of Inspector General of the Bureau of Consumer Financial Protection. H.R. 1090 (Retail Investor Protection Act); Prohibits the Secretary of Labor from prescribing any regulation under the Employee Retirement Income Security Act of 1974 (ERISA) defining the circumstances under which an individual is considered a fiduciary until 60 days after the Securities and Exchange Commission (SEC) issues a final rule governing standards of conduct for brokers and dealers under specified law. Lobbying with regard to rulemaking affecting fiduciary responsibilities of retirement advisors. H.R. 4293 (Affordable Retirement Advice Protection Act); amends ERISA to impose a new best interest standard, requires a rulemaking to be approved by Congress. H.R. 4294 (SAVERS Act); amends the Internal Revenue Code to exempt from the tax on prohibited transactions: (1) the provision of investment advice by a fiduciary to a pension plan, plan participant, or beneficiary which is a best interest recommendation; and (2) any transaction, including a contract for service, between an investment provider and the advice recipient if no more than reasonable compensation is paid for such investment advice and certain disclosures are made with respect to the cost of such advice.

H.R. 1098 (Investor Choice Act of 2015); amends the Securities Exchange Act of 1934 and the Investment Advisers Act of 1940 to revise the authority of the Securities and Exchange Commission (SEC) to prohibit, or impose conditions or limitations on the use of agreements that require customers or clients of any broker, dealer, or municipal securities dealer to arbitrate any future dispute between then arising under the federal securities laws, related rules and regulations, or the rules of a self-regulatory organization if it finds that prohibition, imposition of conditions, or limitations are in the public interest and for the protection of investors. H.R. 1266 (Financial Product Safety Commission Act of 2015); Amends the Consumer Financial Protection Act of 2010 to replace the Consumer Financial Protection Bureau as an independent bureau within the Federal Reserve System, with an independent Financial Product Safety Commission that is to regulate the offering and provision of consumer financial products or services. H.R. 957 (CFPB-IG Act of 2015); Requires Senate confirmation of Inspector General of the Bureau of Consumer Financial Protection. H.R. 1090 (Retail Investor Protection Act); Prohibits the Secretary of Labor from prescribing any regulation under the Employee Retirement Income Security Act of 1974 (ERISA) defining the circumstances under which an individual is considered a fiduciary until 60 days after the Securities and Exchange Commission (SEC) issues a final rule governing standards of conduct for brokers and dealers under specified law. Lobbying with regard to rulemaking affecting fiduciary responsibilities of retirement advisors. H.J.Res. 88; disapproving the rule submitted by the Department of Labor relating to the definition of the term Fiduciary." S.J.Res. 33; providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to the definition of the term fiduciary and the conflict of interest rule with respect to retirement investment advice. H.R. 4293 (Affordable Retirement Advice Protection Act); amends ERISA to impose a new best interest standard, requires a rulemaking to be approved by Congress. H.R. 4294 (SAVERS Act); amends the Internal Revenue Code to exempt from the tax on prohibited transactions: (1) the provision of investment advice by a fiduciary to a pension plan, plan participant, or beneficiary which is a best interest recommendation; and (2) any transaction, including a contract for service, between an investment provider and the advice recipient if no more than reasonable compensation is paid for such investment advice and certain disclosures are made with respect to the cost of such advice. S. 2216/H.R. 4538 (Senior$afe Act of 2015); provides immunity from suit for certain individuals who disclose potential examples of financial exploitation of senior citizens.

H.R. 1098 (Investor Choice Act of 2015); amends the Securities Exchange Act of 1934 and the Investment Advisers Act of 1940 to revise the authority of the Securities and Exchange Commission (SEC) to prohibit, or impose conditions or limitations on the use of agreements that require customers or clients of any broker, dealer, or municipal securities dealer to arbitrate any future dispute between then arising under the federal securities laws, related rules and regulations, or the rules of a self-regulatory organization if it finds that prohibition, imposition of conditions, or limitations are in the public interest and for the protection of investors. H.R. 1266 (Financial Product Safety Commission Act of 2015); Amends the Consumer Financial Protection Act of 2010 to replace the Consumer Financial Protection Bureau as an independent bureau within the Federal Reserve System, with an independent Financial Product Safety Commission that is to regulate the offering and provision of consumer financial products or services. H.R. 957 (CFPB-IG Act of 2015); Requires Senate confirmation of Inspector General of the Bureau of Consumer Financial Protection. H.R. 1090 (Retail Investor Protection Act); Prohibits the Secretary of Labor from prescribing any regulation under the Employee Retirement Income Security Act of 1974 (ERISA) defining the circumstances under which an individual is considered a fiduciary until 60 days after the Securities and Exchange Commission (SEC) issues a final rule governing standards of conduct for brokers and dealers under specified law. Lobbying with regard to rulemaking affecting fiduciary responsibilities of retirement advisors. H.J.Res. 88; disapproving the rule submitted by the Department of Labor relating to the definition of the term Fiduciary." S.J.Res. 33; providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to the definition of the term fiduciary and the conflict of interest rule with respect to retirement investment advice. H.R. 4293 (Affordable Retirement Advice Protection Act); amends ERISA to impose a new best interest standard, requires a rulemaking to be approved by Congress. H.R. 4294 (SAVERS Act); amends the Internal Revenue Code to exempt from the tax on prohibited transactions: (1) the provision of investment advice by a fiduciary to a pension plan, plan participant, or beneficiary which is a best interest recommendation; and (2) any transaction, including a contract for service, between an investment provider and the advice recipient if no more than reasonable compensation is paid for such investment advice and certain disclosures are made with respect to the cost of such advice. S. 2216/H.R. 4538 (Senior$afe Act of 2015); provides immunity from suit for certain individuals who disclose potential examples of financial exploitation of senior citizens.

H.R. 1098 (Investor Choice Act of 2015); amends the Securities Exchange Act of 1934 and the Investment Advisers Act of 1940 to revise the authority of the Securities and Exchange Commission (SEC) to prohibit, or impose conditions or limitations on the use of agreements that require customers or clients of any broker, dealer, or municipal securities dealer to arbitrate any future dispute between then arising under the federal securities laws, related rules and regulations, or the rules of a self-regulatory organization if it finds that prohibition, imposition of conditions, or limitations are in the public interest and for the protection of investors. H.R. 1266 (Financial Product Safety Commission Act of 2015); Amends the Consumer Financial Protection Act of 2010 to replace the Consumer Financial Protection Bureau as an independent bureau within the Federal Reserve System, with an independent Financial Product Safety Commission that is to regulate the offering and provision of consumer financial products or services. H.R. 957 (CFPB-IG Act of 2015); Requires Senate confirmation of Inspector General of the Bureau of Consumer Financial Protection. H.R. 1090 (Retail Investor Protection Act); Prohibits the Secretary of Labor from prescribing any regulation under the Employee Retirement Income Security Act of 1974 (ERISA) defining the circumstances under which an individual is considered a fiduciary until 60 days after the Securities and Exchange Commission (SEC) issues a final rule governing standards of conduct for brokers and dealers under specified law. Lobbying with regard to rulemaking affecting fiduciary responsibilities of retirement advisors. H.J.Res. 88; disapproving the rule submitted by the Department of Labor relating to the definition of the term Fiduciary." S.J.Res. 33; providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Labor relating to the definition of the term fiduciary and the conflict of interest rule with respect to retirement investment advice. H.R. 4293 (Affordable Retirement Advice Protection Act); amends ERISA to impose a new best interest standard, requires a rulemaking to be approved by Congress. H.R. 4294 (SAVERS Act); amends the Internal Revenue Code to exempt from the tax on prohibited transactions: (1) the provision of investment advice by a fiduciary to a pension plan, plan participant, or beneficiary which is a best interest recommendation; and (2) any transaction, including a contract for service, between an investment provider and the advice recipient if no more than reasonable compensation is paid for such investment advice and certain disclosures are made with respect to the cost of such advice. S. 2216/H.R. 4538 (Senior$afe Act of 2015); provides immunity from suit for certain individuals who disclose potential examples of financial exploitation of senior citizens.

Lobbying with regard to the implementation of the SMART Act (Public Law 112-242), generally. Lobbying with regard to the Medicare Secondary Payer Program, generally. S. 1514/H.R. 2649 (Medicare Secondary Payer and Workers' Compensation Settlement Agreements Act of 2015); provides for the application of Medicare secondary payer rules to certain workers' compensation settlement agreements and qualified Medicare set-aside provisions. Lobbying with regard to the Medicaid Third Party Liability Program, generally. S. 884/H.R. 836 (Health Care Safety Net Enhancement Act of 2015); improves access to emergency medical services, and for other purposes. H.R. 1021 (Protecting the Integrity of Medicare Act); amends Title XVIII of the Social Security Act to improve the integrity of the Medicare program, and for other purposes. H.R. 1376 (Patient Choice Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to authorize provisional approval of fast-track products determined by the Secretary of Health and Human Services (HHS) to be adequately safe. H.R. 2300 (Empowering Patients First Act of 2015); provides for incentives to encourage health insurance coverage. H.R. 2653 (American Health Care Reform Act of 2015); repeals the Patient Protection and Affordable Care Act and related reconciliation provisions, to promote patient-centered health care, to provide for the creation of a safe harbor for defendants in medical malpractice actions who demonstrate adherence to clinical practice guidelines. S. 2204 (End of Suffering Act of 2015); respects the Constitutional entitlement to liberty by recognizing the right of an individual to have personal control over the medical assistance and treatment necessary to avoid intolerable physical suffering. H.R.__/S.__ (Behavioral Health Information Technology Act); draft legislation amending the Public Health Service Act to include as a health care provider behavioral and mental health professionals, substance abuse professionals, psychiatric hospitals, certain community mental health centers (including one operated by a county behavioral health agency), and residential or outpatient mental health or substance abuse treatment facilities. H.R. 5403 (Ariel Grace's Law); to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices. S. 2912 (Trickett Wendler Right to Try Act of 2016); to authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes. H.R. 6 (21st Century Cures Act); establishing and appropriating funds, and reforming Medicaid, Medicare, and other reforms. General lobbying with regard to pharmaceutical price-gouging. H.R. 6120 (Secondary Payer Advancement, Rationalization, and Clarification (SPARC) Act); amends title XVIII of the Social Security Act to provide for clarification and rationalization of Medicare prescription drug plan recovery rules for certain claims.

Lobbying with regard to the implementation of the SMART Act (Public Law 112-242), generally. Lobbying with regard to the Medicare Secondary Payer Program, generally. S. 1514/H.R. 2649 (Medicare Secondary Payer and Workers' Compensation Settlement Agreements Act of 2015); provides for the application of Medicare secondary payer rules to certain workers' compensation settlement agreements and qualified Medicare set-aside provisions. Lobbying with regard to the Medicaid Third Party Liability Program, generally. S. 884/H.R. 836 (Health Care Safety Net Enhancement Act of 2015); improves access to emergency medical services, and for other purposes. H.R. 1021 (Protecting the Integrity of Medicare Act); amends Title XVIII of the Social Security Act to improve the integrity of the Medicare program, and for other purposes. H.R. 1376 (Patient Choice Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to authorize provisional approval of fast-track products determined by the Secretary of Health and Human Services (HHS) to be adequately safe. H.R. 2300 (Empowering Patients First Act of 2015); provides for incentives to encourage health insurance coverage. H.R. 2653 (American Health Care Reform Act of 2015); repeals the Patient Protection and Affordable Care Act and related reconciliation provisions, to promote patient-centered health care, to provide for the creation of a safe harbor for defendants in medical malpractice actions who demonstrate adherence to clinical practice guidelines. S. 2204 (End of Suffering Act of 2015); respects the Constitutional entitlement to liberty by recognizing the right of an individual to have personal control over the medical assistance and treatment necessary to avoid intolerable physical suffering. H.R.__/S.__ (Behavioral Health Information Technology Act); draft legislation amending the Public Health Service Act to include as a health care provider behavioral and mental health professionals, substance abuse professionals, psychiatric hospitals, certain community mental health centers (including one operated by a county behavioral health agency), and residential or outpatient mental health or substance abuse treatment facilities. H.R. 5403 (Ariel Grace's Law); to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices. S. 2912 (Trickett Wendler Right to Try Act of 2016); to authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes. H.R. 6 (21st Century Cures Act); establishing and appropriating funds, and reforming Medicaid, Medicare, and other reforms.

Lobbying with regard to the implementation of the SMART Act (Public Law 112-242), generally. Lobbying with regard to the Medicare Secondary Payer Program, generally. Lobbying with regard to the Medicare Third Party Liability Program, generally. S. 884/H.R. 836 (Health Care Safety Net Enhancement Act of 2015); improves access to emergency medical services, and for other purposes. H.R. 1021 (Protecting the Integrity of Medicare Act); amends Title XVIII of the Social Security Act to improve the integrity of the Medicare program, and for other purposes. H.R. 1376 (Patient Choice Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to authorize provisional approval of fast-track products determined by the Secretary of Health and Human Services (HHS) to be adequately safe. H.R. 2300 (Empowering Patients First Act of 2015); provides for incentives to encourage health insurance coverage. H.R. 2653 (American Health Care Reform Act of 2015); repeals the Patient Protection and Affordable Care Act and related reconciliation provisions, to promote patient-centered health care, to provide for the creation of a safe harbor for defendants in medical malpractice actions who demonstrate adherence to clinical practice guidelines. S. 2204 (End of Suffering Act of 2015); respects the Constitutional entitlement to liberty by recognizing the right of an individual to have personal control over the medical assistance and treatment necessary to avoid intolerable physical suffering. H.R.__/S.__ (Behavioral Health Information Technology Act); draft legislation amending the Public Health Service Act to include as a health care provider behavioral and mental health professionals, substance abuse professionals, psychiatric hospitals, certain community mental health centers (including one operated by a county behavioral health agency), and residential or outpatient mental health or substance abuse treatment facilities.

Lobbying with regard to the implementation of the SMART Act (Public Law 112-242), generally. Lobbying with regard to the Medicare Secondary Payer Program, generally. Lobbying with regard to the Medicare Third Party Liability Program, generally. S. 884/H.R. 836 (Health Care Safety Net Enhancement Act of 2015); improves access to emergency medical services, and for other purposes. H.R. 1021 (Protecting the Integrity of Medicare Act); amends Title XVIII of the Social Security Act to improve the integrity of the Medicare program, and for other purposes. H.R. 1376 (Patient Choice Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to authorize provisional approval of fast-track products determined by the Secretary of Health and Human Services (HHS) to be adequately safe. H.R. 2300 (Empowering Patients First Act of 2015); provides for incentives to encourage health insurance coverage. H.R. 2653 (American Health Care Reform Act of 2015); repeals the Patient Protection and Affordable Care Act and related reconciliation provisions, to promote patient-centered health care, to provide for the creation of a safe harbor for defendants in medical malpractice actions who demonstrate adherence to clinical practice guidelines. S. 2204 (End of Suffering Act of 2015); respects the Constitutional entitlement to liberty by recognizing the right of an individual to have personal control over the medical assistance and treatment necessary to avoid intolerable physical suffering. H.R.__/S.__ (Behavioral Health Information Technology Act); draft legislation amending the Public Health Service Act to include as a health care provider behavioral and mental health professionals, substance abuse professionals, psychiatric hospitals, certain community mental health centers (including one operated by a county behavioral health agency), and residential or outpatient mental health or substance abuse treatment facilities.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 1-01-2017; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. S. 3491/H.R. 6423 (Justice for Victims of Fraud Act of 2016); amends the Truth in Lending Act and the Electronic Fund Transfer Act to prohibit pre-dispute arbitration agreements with consumers (i.e., agreements to arbitrate any future disputes between parties instead of pursuing the claims in court) from being valid or enforceable in disputes related to credit card accounts or personal bank accounts that are not subject to a final judgment by a court if the credit card or bank account was not issued in response to a request or application for that account. General lobbying with regard to the regulation of pre-dispute arbitration by the Federal Communications Commission. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 1-01-2017; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. Lobbying with regard to draft legislation related to PCB exposure and liability. General lobbying with regard to pesticide regulations. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. General lobbying with regard to off-label promotion of pharmaceutical products. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process. H.R. 5983 (Financial CHOICE Act of 2016); repealing provisions of the Dodd-Frank Act.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 07-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 07-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 10-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 10-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. Lobbying with regard to draft legislation related to PCB exposure and liability. General lobbying with regard to pesticide regulations. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process. H.R. 5983 (Financial CHOICE Act of 2016); repealing provisions of the Dodd-Frank Act.

Lobbying with regard to limitations of liability and preemption of state-based causes of action as they relate to cybersecurity proposals generally. General lobbying with regard to the SAFETY Act (Public Law 107-296) and cybersecurity. H.R. 2205/S. 961 (Data Security Act); protects information relating to consumers, to require notice of security breaches, and for other purposes. S. 754 (Cybersecurity Information Sharing Act); improves cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes. H.R. 1770 (Data Security and Breach Notification Act of 2015); requires certain entities who collect and maintain personal information of individuals to secure such information and to provide notice to such individuals in the case of a breach of security involving such information, and for other purposes. H.R. 1731 (National Cybersecurity Protection Advancement Act of 2015); amends the Homeland Security Act of 2002 to enhance multi-directional sharing of information related to cybersecurity risks and strengthen privacy and civil liberties protections, and for other purposes. H.R. 1560 (Protecting Cyber Networks Act); improves cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes. S. 1158 (Consumer Privacy Protection Act of 2015); ensures the privacy and security of sensitive personal information, to prevent and mitigate identity theft, to provide notice of security breaches involving sensitive personal information, and to enhance law enforcement assistance and other protections against security breaches, fraudulent access, and misuse of personal information. Lobbying with regard to the FCC Broadband Internet Access Service providers and cybersecurity, with specific regard to customer notification, multi-factor authentication, and third party accountability.

Lobbying with regard to limitations of liability and preemption of state-based causes of action as they relate to cybersecurity proposals generally. General lobbying with regard to the SAFETY Act (Public Law 107-296) and cybersecurity. H.R. 2205/S. 961 (Data Security Act); protects information relating to consumers, to require notice of security breaches, and for other purposes. S. 754 (Cybersecurity Information Sharing Act); improves cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes. H.R. 1770 (Data Security and Breach Notification Act of 2015); requires certain entities who collect and maintain personal information of individuals to secure such information and to provide notice to such individuals in the case of a breach of security involving such information, and for other purposes. H.R. 1731 (National Cybersecurity Protection Advancement Act of 2015); amends the Homeland Security Act of 2002 to enhance multi-directional sharing of information related to cybersecurity risks and strengthen privacy and civil liberties protections, and for other purposes. H.R. 1560 (Protecting Cyber Networks Act); improves cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes. S. 1158 (Consumer Privacy Protection Act of 2015); ensures the privacy and security of sensitive personal information, to prevent and mitigate identity theft, to provide notice of security breaches involving sensitive personal information, and to enhance law enforcement assistance and other protections against security breaches, fraudulent access, and misuse of personal information. Lobbying with regard to the FCC Broadband Internet Access Service providers and cybersecurity, with specific regard to customer notification, multi-factor authentication, and third party accountability.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. General lobbying with regard to altering the requirement of complete diversity. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. General lobbying with regard to regulatory reform issues. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. S. 3446/H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period. General lobbying with respect to diversity jurisdiction and potential changes to the jurisdiction rules. S. 3155/H.R. 889 (Foreign Cultural Exchange Jurisdictional Immunity Clarification Act); to amend chapter 97 of title 28, United States Code, to clarify the exception to foreign sovereign immunity set forth in section 1605(a)(3) of such title) S. 2763/H.R. 6130 (Holocaust Expropriated Art Recovery Act of 2016); to provide the victims of Holocaust-era persecution and their heirs a fair opportunity to recover works of art confiscated or misappropriated by the Nazis.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. S. 3446/H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period. General lobbying with respect to diversity jurisdiction and potential changes to the jurisdiction rules. S. 3155/H.R. 889 (Foreign Cultural Exchange Jurisdictional Immunity Clarification Act); to amend chapter 97 of title 28, United States Code, to clarify the exception to foreign sovereign immunity set forth in section 1605(a)(3) of such title) S. 2763/H.R. 6130 (Holocaust Expropriated Art Recovery Act of 2016); to provide the victims of Holocaust-era persecution and their heirs a fair opportunity to recover works of art confiscated or misappropriated by the Nazis.

H.R. 1599/S. 2621 (Safe and Accurate Food Labeling Act of 2015); amends the Federal Food, Drug, and Cosmetic Act with respect to food produced from, containing, or consisting of a bioengineered organism, the labeling of natural foods. H.R. 2017/S. 2217 (Common Sense Nutrition Disclosure Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to improve and clarify certain disclosure requirements for restaurants and similar retail food establishments, and to amend the authority to bring proceedings under section 403A. General lobbying with regard to food labeling. S. 2947 (Food Date Labeling Act of 2016); establishes requirements regarding quality dates and safety dates in food labeling.

H.R. 1599/S. 2621 (Safe and Accurate Food Labeling Act of 2015); amends the Federal Food, Drug, and Cosmetic Act with respect to food produced from, containing, or consisting of a bioengineered organism, the labeling of natural foods. H.R. 2017/S. 2217 (Common Sense Nutrition Disclosure Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to improve and clarify certain disclosure requirements for restaurants and similar retail food establishments, and to amend the authority to bring proceedings under section 403A. General lobbying with regard to food labeling. S. 2947 (Food Date Labeling Act of 2016); establishes requirements regarding quality dates and safety dates in food labeling.

H.R. 1599/S. 2621 (Safe and Accurate Food Labeling Act of 2015); amends the Federal Food, Drug, and Cosmetic Act with respect to food produced from, containing, or consisting of a bioengineered organism, the labeling of natural foods. H.R. 2017/S. 2217 (Common Sense Nutrition Disclosure Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to improve and clarify certain disclosure requirements for restaurants and similar retail food establishments, and to amend the authority to bring proceedings under section 403A. General lobbying with regard to food labeling. S. 2947 (Food Date Labeling Act of 2016); establishes requirements regarding quality dates and safety dates in food labeling.

H.R. 1599/S. 2621 (Safe and Accurate Food Labeling Act of 2015); amends the Federal Food, Drug, and Cosmetic Act with respect to food produced from, containing, or consisting of a bioengineered organism, the labeling of natural foods. H.R. 2017/S. 2217 (Common Sense Nutrition Disclosure Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to improve and clarify certain disclosure requirements for restaurants and similar retail food establishments, and to amend the authority to bring proceedings under section 403A. General lobbying with regard to food labeling.

Lobbying with regard to limitations of liability and preemption of state-based causes of action as they relate to cybersecurity proposals generally. General lobbying with regard to the SAFETY Act (Public Law 107-296) and cybersecurity. H.R. 2205/S. 961 (Data Security Act); protects information relating to consumers, to require notice of security breaches, and for other purposes. S. 754 (Cybersecurity Information Sharing Act); improves cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes. H.R. 1770 (Data Security and Breach Notification Act of 2015); requires certain entities who collect and maintain personal information of individuals to secure such information and to provide notice to such individuals in the case of a breach of security involving such information, and for other purposes. H.R. 1731 (National Cybersecurity Protection Advancement Act of 2015); amends the Homeland Security Act of 2002 to enhance multi-directional sharing of information related to cybersecurity risks and strengthen privacy and civil liberties protections, and for other purposes. H.R. 1560 (Protecting Cyber Networks Act); improves cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes. S. 1158 (Consumer Privacy Protection Act of 2015); ensures the privacy and security of sensitive personal information, to prevent and mitigate identity theft, to provide notice of security breaches involving sensitive personal information, and to enhance law enforcement assistance and other protections against security breaches, fraudulent access, and misuse of personal information. Lobbying with regard to the FCC Broadband Internet Access Service providers and cybersecurity, with specific regard to customer notification, multi-factor authentication, and third party accountability.

Lobbying with regard to limitations of liability and preemption of state-based causes of action as they relate to cybersecurity proposals generally. General lobbying with regard to the SAFETY Act (Public Law 107-296) and cybersecurity. H.R. 2205/S. 961 (Data Security Act); protects information relating to consumers, to require notice of security breaches, and for other purposes. S. 754 (Cybersecurity Information Sharing Act); improves cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes. H.R. 1770 (Data Security and Breach Notification Act of 2015); requires certain entities who collect and maintain personal information of individuals to secure such information and to provide notice to such individuals in the case of a breach of security involving such information, and for other purposes. H.R. 1731 (National Cybersecurity Protection Advancement Act of 2015); amends the Homeland Security Act of 2002 to enhance multi-directional sharing of information related to cybersecurity risks and strengthen privacy and civil liberties protections, and for other purposes. H.R. 1560 (Protecting Cyber Networks Act); improves cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes. S. 1158 (Consumer Privacy Protection Act of 2015); ensures the privacy and security of sensitive personal information, to prevent and mitigate identity theft, to provide notice of security breaches involving sensitive personal information, and to enhance law enforcement assistance and other protections against security breaches, fraudulent access, and misuse of personal information. Lobbying with regard to the FCC Broadband Internet Access Service providers and cybersecurity, with specific regard to customer notification, multi-factor authentication, and third party accountability.

Lobbying with regard to limitations of liability and preemption of state-based causes of action as they relate to cybersecurity proposals generally. General lobbying with regard to the SAFETY Act (Public Law 107-296) and cybersecurity. H.R. 2205/S. 961 (Data Security Act); protects information relating to consumers, to require notice of security breaches, and for other purposes. S. 754 (Cybersecurity Information Sharing Act); improves cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes. H.R. 1770 (Data Security and Breach Notification Act of 2015); requires certain entities who collect and maintain personal information of individuals to secure such information and to provide notice to such individuals in the case of a breach of security involving such information, and for other purposes. H.R. 1731 (National Cybersecurity Protection Advancement Act of 2015); amends the Homeland Security Act of 2002 to enhance multi-directional sharing of information related to cybersecurity risks and strengthen privacy and civil liberties protections, and for other purposes. H.R. 1560 (Protecting Cyber Networks Act); improves cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes. S. 1158 (Consumer Privacy Protection Act of 2015); ensures the privacy and security of sensitive personal information, to prevent and mitigate identity theft, to provide notice of security breaches involving sensitive personal information, and to enhance law enforcement assistance and other protections against security breaches, fraudulent access, and misuse of personal information. Lobbying with regard to the FCC Broadband Internet Access Service providers and cybersecurity, with specific regard to customer notification, multi-factor authentication, and third party accountability.

Lobbying with regard to limitations of liability and preemption of state-based causes of action as they relate to cybersecurity proposals generally. General lobbying with regard to the SAFETY Act (Public Law 107-296) and cybersecurity. H.R. 2205/S. 961 (Data Security Act); protects information relating to consumers, to require notice of security breaches, and for other purposes. S. 754 (Cybersecurity Information Sharing Act); improves cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes. H.R. 1770 (Data Security and Breach Notification Act of 2015); requires certain entities who collect and maintain personal information of individuals to secure such information and to provide notice to such individuals in the case of a breach of security involving such information, and for other purposes. H.R. 1731 (National Cybersecurity Protection Advancement Act of 2015); amends the Homeland Security Act of 2002 to enhance multi-directional sharing of information related to cybersecurity risks and strengthen privacy and civil liberties protections, and for other purposes. H.R. 1560 (Protecting Cyber Networks Act); improves cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes. S. 1158 (Consumer Privacy Protection Act of 2015); ensures the privacy and security of sensitive personal information, to prevent and mitigate identity theft, to provide notice of security breaches involving sensitive personal information, and to enhance law enforcement assistance and other protections against security breaches, fraudulent access, and misuse of personal information. Lobbying with regard to the FCC Broadband Internet Access Service providers and cybersecurity, with specific regard to customer notification, multi-factor authentication, and third party accountability.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. General lobbying with regard to altering the requirement of complete diversity. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. General lobbying with regard to regulatory reform issues. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. S. 3446/H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period. General lobbying with respect to diversity jurisdiction and potential changes to the jurisdiction rules. S. 3155/H.R. 889 (Foreign Cultural Exchange Jurisdictional Immunity Clarification Act); to amend chapter 97 of title 28, United States Code, to clarify the exception to foreign sovereign immunity set forth in section 1605(a)(3) of such title) S. 2763/H.R. 6130 (Holocaust Expropriated Art Recovery Act of 2016); to provide the victims of Holocaust-era persecution and their heirs a fair opportunity to recover works of art confiscated or misappropriated by the Nazis.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. S. 3446/H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period. General lobbying with respect to diversity jurisdiction and potential changes to the jurisdiction rules. S. 3155/H.R. 889 (Foreign Cultural Exchange Jurisdictional Immunity Clarification Act); to amend chapter 97 of title 28, United States Code, to clarify the exception to foreign sovereign immunity set forth in section 1605(a)(3) of such title) S. 2763/H.R. 6130 (Holocaust Expropriated Art Recovery Act of 2016); to provide the victims of Holocaust-era persecution and their heirs a fair opportunity to recover works of art confiscated or misappropriated by the Nazis.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. S. 3446/H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period. General lobbying with respect to diversity jurisdiction and potential changes to the jurisdiction rules. S. 3155/H.R. 889 (Foreign Cultural Exchange Jurisdictional Immunity Clarification Act); to amend chapter 97 of title 28, United States Code, to clarify the exception to foreign sovereign immunity set forth in section 1605(a)(3) of such title) S. 2763/H.R. 6130 (Holocaust Expropriated Art Recovery Act of 2016); to provide the victims of Holocaust-era persecution and their heirs a fair opportunity to recover works of art confiscated or misappropriated by the Nazis.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. General lobbying with regard to altering the requirement of complete diversity. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. General lobbying with regard to regulatory reform issues. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. S. 3446/H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period. General lobbying with respect to diversity jurisdiction and potential changes to the jurisdiction rules. S. 3155/H.R. 889 (Foreign Cultural Exchange Jurisdictional Immunity Clarification Act); to amend chapter 97 of title 28, United States Code, to clarify the exception to foreign sovereign immunity set forth in section 1605(a)(3) of such title) S. 2763/H.R. 6130 (Holocaust Expropriated Art Recovery Act of 2016); to provide the victims of Holocaust-era persecution and their heirs a fair opportunity to recover works of art confiscated or misappropriated by the Nazis.

H.R. 1599/S. 2621 (Safe and Accurate Food Labeling Act of 2015); amends the Federal Food, Drug, and Cosmetic Act with respect to food produced from, containing, or consisting of a bioengineered organism, the labeling of natural foods. H.R. 2017/S. 2217 (Common Sense Nutrition Disclosure Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to improve and clarify certain disclosure requirements for restaurants and similar retail food establishments, and to amend the authority to bring proceedings under section 403A. General lobbying with regard to food labeling. S. 2947 (Food Date Labeling Act of 2016); establishes requirements regarding quality dates and safety dates in food labeling.

H.R. 1599/S. 2621 (Safe and Accurate Food Labeling Act of 2015); amends the Federal Food, Drug, and Cosmetic Act with respect to food produced from, containing, or consisting of a bioengineered organism, the labeling of natural foods. H.R. 2017/S. 2217 (Common Sense Nutrition Disclosure Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to improve and clarify certain disclosure requirements for restaurants and similar retail food establishments, and to amend the authority to bring proceedings under section 403A. General lobbying with regard to food labeling. S. 2947 (Food Date Labeling Act of 2016); establishes requirements regarding quality dates and safety dates in food labeling.

H.R. 1599/S. 2621 (Safe and Accurate Food Labeling Act of 2015); amends the Federal Food, Drug, and Cosmetic Act with respect to food produced from, containing, or consisting of a bioengineered organism, the labeling of natural foods. H.R. 2017/S. 2217 (Common Sense Nutrition Disclosure Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to improve and clarify certain disclosure requirements for restaurants and similar retail food establishments, and to amend the authority to bring proceedings under section 403A. General lobbying with regard to food labeling.

H.R. 1599/S. 2621 (Safe and Accurate Food Labeling Act of 2015); amends the Federal Food, Drug, and Cosmetic Act with respect to food produced from, containing, or consisting of a bioengineered organism, the labeling of natural foods. H.R. 2017/S. 2217 (Common Sense Nutrition Disclosure Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to improve and clarify certain disclosure requirements for restaurants and similar retail food establishments, and to amend the authority to bring proceedings under section 403A. General lobbying with regard to food labeling. S. 2947 (Food Date Labeling Act of 2016); establishes requirements regarding quality dates and safety dates in food labeling.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 1-01-2017; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. S. 3491/H.R. 6423 (Justice for Victims of Fraud Act of 2016); amends the Truth in Lending Act and the Electronic Fund Transfer Act to prohibit pre-dispute arbitration agreements with consumers (i.e., agreements to arbitrate any future disputes between parties instead of pursuing the claims in court) from being valid or enforceable in disputes related to credit card accounts or personal bank accounts that are not subject to a final judgment by a court if the credit card or bank account was not issued in response to a request or application for that account. General lobbying with regard to the regulation of pre-dispute arbitration by the Federal Communications Commission. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 1-01-2017; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. Lobbying with regard to draft legislation related to PCB exposure and liability. General lobbying with regard to pesticide regulations. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. General lobbying with regard to off-label promotion of pharmaceutical products. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process. H.R. 5983 (Financial CHOICE Act of 2016); repealing provisions of the Dodd-Frank Act.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 10-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 10-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. Lobbying with regard to draft legislation related to PCB exposure and liability. General lobbying with regard to pesticide regulations. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process. H.R. 5983 (Financial CHOICE Act of 2016); repealing provisions of the Dodd-Frank Act.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 07-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 07-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 04-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 04-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 07-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 07-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 04-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 04-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 10-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 10-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. Lobbying with regard to draft legislation related to PCB exposure and liability. General lobbying with regard to pesticide regulations. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process. H.R. 5983 (Financial CHOICE Act of 2016); repealing provisions of the Dodd-Frank Act.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 1-01-2017; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. S. 3491/H.R. 6423 (Justice for Victims of Fraud Act of 2016); amends the Truth in Lending Act and the Electronic Fund Transfer Act to prohibit pre-dispute arbitration agreements with consumers (i.e., agreements to arbitrate any future disputes between parties instead of pursuing the claims in court) from being valid or enforceable in disputes related to credit card accounts or personal bank accounts that are not subject to a final judgment by a court if the credit card or bank account was not issued in response to a request or application for that account. General lobbying with regard to the regulation of pre-dispute arbitration by the Federal Communications Commission. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 1-01-2017; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. Lobbying with regard to draft legislation related to PCB exposure and liability. General lobbying with regard to pesticide regulations. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. General lobbying with regard to off-label promotion of pharmaceutical products. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process. H.R. 5983 (Financial CHOICE Act of 2016); repealing provisions of the Dodd-Frank Act.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 10-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 10-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. Lobbying with regard to draft legislation related to PCB exposure and liability. General lobbying with regard to pesticide regulations. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process. H.R. 5983 (Financial CHOICE Act of 2016); repealing provisions of the Dodd-Frank Act.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 04-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 04-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 07-01-2016; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 07-01-2016; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process.

S.__/H.R.__ (Fairness in Nursing Home Arbitration Act); draft legislation not formally introduced as of 1-01-2017; relating to the use of arbitration agreements to resolve disputes involving nursing home cases and nursing home contracts. Lobbying with regard to CMS rulemaking on mandatory pre-dispute arbitration in nursing home residency contracts. Lobbying with regard to the Consumer Financial Protection Bureau rulemaking on forced arbitration. Lobbying with regard to the Education Department Rulemaking on forced arbitration. General lobbying with regard to the Federal Communications Commission and forced arbitration. S. 1122/H.R. 2079 (Court Legal Access and Student Support (CLASS) Act of 2015); makes procedures for the enforcement of arbitration agreements inapplicable to an enrollment agreement between a student and an institution of higher education (IHE). H.R. 2087/S. 1133 (Arbitration Fairness Act); prohibits mandatory, pre-dispute arbitration in consumer contracts. General lobbying with regard to the enforceability of mandatory, pre-dispute arbitration provisions in employment and consumer contracts, including financial consumer contracts and servicemember contracts for consumer products. General lobbying with regard to the ability of consumers and injured parties to bring class actions, including limitations on the ability to bring class actions involving the securities industry. S. 3491/H.R. 6423 (Justice for Victims of Fraud Act of 2016); amends the Truth in Lending Act and the Electronic Fund Transfer Act to prohibit pre-dispute arbitration agreements with consumers (i.e., agreements to arbitrate any future disputes between parties instead of pursuing the claims in court) from being valid or enforceable in disputes related to credit card accounts or personal bank accounts that are not subject to a final judgment by a court if the credit card or bank account was not issued in response to a request or application for that account. General lobbying with regard to the regulation of pre-dispute arbitration by the Federal Communications Commission. General lobbying on consumer protection provisions related to servicemember contracts for consumer products. S.__/H.R.__ (Civil Legal Access to Strong Safeguards); draft legislation not formally introduced as of 1-01-2017; amends the Class Action Fairness Act to ensure that consumers and injured parties in a class action are treated fairly and equally. General Lobbying with regard to the preemption of states causes of action involving medical device and drug manufacturers. General lobbying with regard to asbestos exposure and related health and environmental issues. S. 357/H.R. 526 (Furthering Asbestos Claim Transparency Act); amends Title 11 of the United States Code to require the public disclosure by trusts established under Section 524(g) of such Title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. H.R. 1199 (Innocent Sellers Fairness Act); prevents undue disruption of interstate commerce by limiting civil actions brought against persons whose only role with regard to a product in the stream of commerce is as a lawful seller of the product. General lobbying with regard to alternative litigation funding. H.R. 54 (Frank Lautenberg Memorial Secure Chemical Facilities Act)/S. 697 (Frank R. Lautenberg Chemical Safety for the 21st Century Act)/S.725 (Alan Reinstein and Trevor Schaefer Toxic Chemical Protection Act); amends the Toxic Substances Control Act to reauthorize and modernize that Act, and for other purposes. H.R. 2576 (TSCA Modernization Act); provides for the safe and efficient flow of chemicals in interstate and foreign commerce; specific interest in provisions that would preempt state-based causes of action. Lobbying with regard to draft legislation related to PCB exposure and liability. General lobbying with regard to pesticide regulations. General lobbying with regard to the ongoing development of a proposed TAFT-TTIP trade agreement, specific interest in effect the trade agreement would have on state-based causes of action. General lobbying with regard to warranties of Energy Star-rated products and ability of consumers to bring a class action against manufacturers of Energy Star-rated products. H.R. 504/S. 1038 (Energy Star Program Integrity Act); clarifies that no express or implied warranty is provided by reason of a disclosure relating to voluntary participation in the Energy Star program. H.R. 2030/S. 700 (READ Act); amends the Asbestos Information Act of 1988 to establish a public database of asbestos-containing products, to require public disclosure of information pertaining to the manufacture, processing, distribution, and use of asbestos-containing products in the United States. Lobbying with regard to updating generic drug labeling rulemaking and responsibilities. H.R. 2841 (FAST Generics Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to prohibit the license holder of a Food and Drug Administration (FDA)-approved drug or biological product from restricting availability of the medication for testing by a product developer seeking to develop a drug, generic drug, or biosimilar, including restricting availability with a risk evaluation and mitigation strategy (REMS). S. 3056 (Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016); provides for certain causes of action relating to delays of generic drugs and biosimilar biological products. Lobbying with regard to biosimilar naming and labeling. General lobbying with regard to off-label promotion of pharmaceutical products. H.R. 3304 (Foreign Manufacturers Legal Accountability Act of 2015); Requires foreign manufacturers of products imported into the US to establish registered agents in the United States who are authorized to accept service of process against such manufacturers. S. 2506 (Restoring Statutory Rights and Interests of the States Act of 2016); amends the Federal Arbitration Act to invalidate arbitration agreements between parties in certain commercial contracts or transactions if they require arbitration of a claim for damages or injunctive relief brought by an individual or small business arising from the alleged violation of a federal or state statute, the U.S. Constitution, or a state constitution, unless the written agreement to arbitrate is entered into by both parties after the claim has arisen and pertains solely to an existing claim. S. 1014 (Personal Care Products Safety Act); amends the Federal Food, Drug, and Cosmetic Act to require cosmetics companies to register their facilities with the Food and Drug Administration (FDA) and to submit to the FDA cosmetic ingredient statements that include the amounts of a cosmetic's ingredients. H.R. 4075 (Cosmetic Modernization Amendments of 2016); amends the Federal Food, Drug, and Cosmetic Act to establish new procedures and requirements for the registration of cosmetic manufacturing establishments, the submission of cosmetic and ingredient statements, and the reporting of serious cosmetic adverse events. H.R. 1195 (Bureau of Consumer Financial Protection Advisory Boards Act); amends the Consumer Financial Protection Act of 2010 to establish advisory boards. General lobbying regarding altering CFPB's operational structure and rulemaking authority. H.R. 1486 (Taking Account of Bureaucrats Spending Act of 2015 (TABS Act); amends the Consumer Financial Protection Act of 2010 to bring the Bureau of Consumer Financial Protection into the regular appropriations process. H.R. 5983 (Financial CHOICE Act of 2016); repealing provisions of the Dodd-Frank Act.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. S. 3446/H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period. General lobbying with respect to diversity jurisdiction and potential changes to the jurisdiction rules. S. 3155/H.R. 889 (Foreign Cultural Exchange Jurisdictional Immunity Clarification Act); to amend chapter 97 of title 28, United States Code, to clarify the exception to foreign sovereign immunity set forth in section 1605(a)(3) of such title) S. 2763/H.R. 6130 (Holocaust Expropriated Art Recovery Act of 2016); to provide the victims of Holocaust-era persecution and their heirs a fair opportunity to recover works of art confiscated or misappropriated by the Nazis.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. General lobbying with regard to altering the requirement of complete diversity. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. General lobbying with regard to regulatory reform issues. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. S. 3446/H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period. General lobbying with respect to diversity jurisdiction and potential changes to the jurisdiction rules. S. 3155/H.R. 889 (Foreign Cultural Exchange Jurisdictional Immunity Clarification Act); to amend chapter 97 of title 28, United States Code, to clarify the exception to foreign sovereign immunity set forth in section 1605(a)(3) of such title) S. 2763/H.R. 6130 (Holocaust Expropriated Art Recovery Act of 2016); to provide the victims of Holocaust-era persecution and their heirs a fair opportunity to recover works of art confiscated or misappropriated by the Nazis.

Lobbying with regard to limitations of liability and preemption of state-based causes of action as they relate to cybersecurity proposals generally. General lobbying with regard to the SAFETY Act (Public Law 107-296) and cybersecurity. H.R. 2205/S. 961 (Data Security Act); protects information relating to consumers, to require notice of security breaches, and for other purposes. S. 754 (Cybersecurity Information Sharing Act); improves cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes. H.R. 1770 (Data Security and Breach Notification Act of 2015); requires certain entities who collect and maintain personal information of individuals to secure such information and to provide notice to such individuals in the case of a breach of security involving such information, and for other purposes. H.R. 1731 (National Cybersecurity Protection Advancement Act of 2015); amends the Homeland Security Act of 2002 to enhance multi-directional sharing of information related to cybersecurity risks and strengthen privacy and civil liberties protections, and for other purposes. H.R. 1560 (Protecting Cyber Networks Act); improves cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes. S. 1158 (Consumer Privacy Protection Act of 2015); ensures the privacy and security of sensitive personal information, to prevent and mitigate identity theft, to provide notice of security breaches involving sensitive personal information, and to enhance law enforcement assistance and other protections against security breaches, fraudulent access, and misuse of personal information. Lobbying with regard to the FCC Broadband Internet Access Service providers and cybersecurity, with specific regard to customer notification, multi-factor authentication, and third party accountability.

Lobbying with regard to limitations of liability and preemption of state-based causes of action as they relate to cybersecurity proposals generally. General lobbying with regard to the SAFETY Act (Public Law 107-296) and cybersecurity. H.R. 2205/S. 961 (Data Security Act); protects information relating to consumers, to require notice of security breaches, and for other purposes. S. 754 (Cybersecurity Information Sharing Act); improves cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes. H.R. 1770 (Data Security and Breach Notification Act of 2015); requires certain entities who collect and maintain personal information of individuals to secure such information and to provide notice to such individuals in the case of a breach of security involving such information, and for other purposes. H.R. 1731 (National Cybersecurity Protection Advancement Act of 2015); amends the Homeland Security Act of 2002 to enhance multi-directional sharing of information related to cybersecurity risks and strengthen privacy and civil liberties protections, and for other purposes. H.R. 1560 (Protecting Cyber Networks Act); improves cybersecurity in the United States through enhanced sharing of information about cybersecurity threats, and for other purposes. S. 1158 (Consumer Privacy Protection Act of 2015); ensures the privacy and security of sensitive personal information, to prevent and mitigate identity theft, to provide notice of security breaches involving sensitive personal information, and to enhance law enforcement assistance and other protections against security breaches, fraudulent access, and misuse of personal information. Lobbying with regard to the FCC Broadband Internet Access Service providers and cybersecurity, with specific regard to customer notification, multi-factor authentication, and third party accountability.

H.R. 2262 (SPACE Act of 2015); facilitates a pro-growth environment for the developing commercial space industry by encouraging private sector investment and creating more stable and predictable regulatory conditions. General lobbying with regard to the Internet of Things.

H.R. 2262 (SPACE Act of 2015); facilitates a pro-growth environment for the developing commercial space industry by encouraging private sector investment and creating more stable and predictable regulatory conditions. General lobbying with regard to the Internet of Things.

Lobbying with regard to the implementation of the SMART Act (Public Law 112-242), generally. Lobbying with regard to the Medicare Secondary Payer Program, generally. Lobbying with regard to the Medicare Third Party Liability Program, generally. S. 884/H.R. 836 (Health Care Safety Net Enhancement Act of 2015); improves access to emergency medical services, and for other purposes. H.R. 1021 (Protecting the Integrity of Medicare Act); amends Title XVIII of the Social Security Act to improve the integrity of the Medicare program, and for other purposes. H.R. 1376 (Patient Choice Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to authorize provisional approval of fast-track products determined by the Secretary of Health and Human Services (HHS) to be adequately safe. H.R. 2300 (Empowering Patients First Act of 2015); provides for incentives to encourage health insurance coverage. H.R. 2653 (American Health Care Reform Act of 2015); repeals the Patient Protection and Affordable Care Act and related reconciliation provisions, to promote patient-centered health care, to provide for the creation of a safe harbor for defendants in medical malpractice actions who demonstrate adherence to clinical practice guidelines. S. 2204 (End of Suffering Act of 2015); respects the Constitutional entitlement to liberty by recognizing the right of an individual to have personal control over the medical assistance and treatment necessary to avoid intolerable physical suffering. H.R.__/S.__ (Behavioral Health Information Technology Act); draft legislation amending the Public Health Service Act to include as a health care provider behavioral and mental health professionals, substance abuse professionals, psychiatric hospitals, certain community mental health centers (including one operated by a county behavioral health agency), and residential or outpatient mental health or substance abuse treatment facilities.

Lobbying with regard to the implementation of the SMART Act (Public Law 112-242), generally. Lobbying with regard to the Medicare Secondary Payer Program, generally. Lobbying with regard to the Medicare Third Party Liability Program, generally. S. 884/H.R. 836 (Health Care Safety Net Enhancement Act of 2015); improves access to emergency medical services, and for other purposes. H.R. 1021 (Protecting the Integrity of Medicare Act); amends Title XVIII of the Social Security Act to improve the integrity of the Medicare program, and for other purposes. H.R. 1376 (Patient Choice Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to authorize provisional approval of fast-track products determined by the Secretary of Health and Human Services (HHS) to be adequately safe. H.R. 2300 (Empowering Patients First Act of 2015); provides for incentives to encourage health insurance coverage. H.R. 2653 (American Health Care Reform Act of 2015); repeals the Patient Protection and Affordable Care Act and related reconciliation provisions, to promote patient-centered health care, to provide for the creation of a safe harbor for defendants in medical malpractice actions who demonstrate adherence to clinical practice guidelines. S. 2204 (End of Suffering Act of 2015); respects the Constitutional entitlement to liberty by recognizing the right of an individual to have personal control over the medical assistance and treatment necessary to avoid intolerable physical suffering. H.R.__/S.__ (Behavioral Health Information Technology Act); draft legislation amending the Public Health Service Act to include as a health care provider behavioral and mental health professionals, substance abuse professionals, psychiatric hospitals, certain community mental health centers (including one operated by a county behavioral health agency), and residential or outpatient mental health or substance abuse treatment facilities.

Lobbying with regard to the implementation of the SMART Act (Public Law 112-242), generally. Lobbying with regard to the Medicare Secondary Payer Program, generally. S. 1514/H.R. 2649 (Medicare Secondary Payer and Workers' Compensation Settlement Agreements Act of 2015); provides for the application of Medicare secondary payer rules to certain workers' compensation settlement agreements and qualified Medicare set-aside provisions. Lobbying with regard to the Medicaid Third Party Liability Program, generally. S. 884/H.R. 836 (Health Care Safety Net Enhancement Act of 2015); improves access to emergency medical services, and for other purposes. H.R. 1021 (Protecting the Integrity of Medicare Act); amends Title XVIII of the Social Security Act to improve the integrity of the Medicare program, and for other purposes. H.R. 1376 (Patient Choice Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to authorize provisional approval of fast-track products determined by the Secretary of Health and Human Services (HHS) to be adequately safe. H.R. 2300 (Empowering Patients First Act of 2015); provides for incentives to encourage health insurance coverage. H.R. 2653 (American Health Care Reform Act of 2015); repeals the Patient Protection and Affordable Care Act and related reconciliation provisions, to promote patient-centered health care, to provide for the creation of a safe harbor for defendants in medical malpractice actions who demonstrate adherence to clinical practice guidelines. S. 2204 (End of Suffering Act of 2015); respects the Constitutional entitlement to liberty by recognizing the right of an individual to have personal control over the medical assistance and treatment necessary to avoid intolerable physical suffering. H.R.__/S.__ (Behavioral Health Information Technology Act); draft legislation amending the Public Health Service Act to include as a health care provider behavioral and mental health professionals, substance abuse professionals, psychiatric hospitals, certain community mental health centers (including one operated by a county behavioral health agency), and residential or outpatient mental health or substance abuse treatment facilities. H.R. 5403 (Ariel Grace's Law); to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices. S. 2912 (Trickett Wendler Right to Try Act of 2016); to authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes. H.R. 6 (21st Century Cures Act); establishing and appropriating funds, and reforming Medicaid, Medicare, and other reforms.

Lobbying with regard to the implementation of the SMART Act (Public Law 112-242), generally. Lobbying with regard to the Medicare Secondary Payer Program, generally. S. 1514/H.R. 2649 (Medicare Secondary Payer and Workers' Compensation Settlement Agreements Act of 2015); provides for the application of Medicare secondary payer rules to certain workers' compensation settlement agreements and qualified Medicare set-aside provisions. Lobbying with regard to the Medicaid Third Party Liability Program, generally. S. 884/H.R. 836 (Health Care Safety Net Enhancement Act of 2015); improves access to emergency medical services, and for other purposes. H.R. 1021 (Protecting the Integrity of Medicare Act); amends Title XVIII of the Social Security Act to improve the integrity of the Medicare program, and for other purposes. H.R. 1376 (Patient Choice Act of 2015); amends the Federal Food, Drug, and Cosmetic Act to authorize provisional approval of fast-track products determined by the Secretary of Health and Human Services (HHS) to be adequately safe. H.R. 2300 (Empowering Patients First Act of 2015); provides for incentives to encourage health insurance coverage. H.R. 2653 (American Health Care Reform Act of 2015); repeals the Patient Protection and Affordable Care Act and related reconciliation provisions, to promote patient-centered health care, to provide for the creation of a safe harbor for defendants in medical malpractice actions who demonstrate adherence to clinical practice guidelines. S. 2204 (End of Suffering Act of 2015); respects the Constitutional entitlement to liberty by recognizing the right of an individual to have personal control over the medical assistance and treatment necessary to avoid intolerable physical suffering. H.R.__/S.__ (Behavioral Health Information Technology Act); draft legislation amending the Public Health Service Act to include as a health care provider behavioral and mental health professionals, substance abuse professionals, psychiatric hospitals, certain community mental health centers (including one operated by a county behavioral health agency), and residential or outpatient mental health or substance abuse treatment facilities. H.R. 5403 (Ariel Grace's Law); to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices. S. 2912 (Trickett Wendler Right to Try Act of 2016); to authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes. H.R. 6 (21st Century Cures Act); establishing and appropriating funds, and reforming Medicaid, Medicare, and other reforms. General lobbying with regard to pharmaceutical price-gouging. H.R. 6120 (Secondary Payer Advancement, Rationalization, and Clarification (SPARC) Act); amends title XVIII of the Social Security Act to provide for clarification and rationalization of Medicare prescription drug plan recovery rules for certain claims.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. S. 3446/H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period. General lobbying with respect to diversity jurisdiction and potential changes to the jurisdiction rules. S. 3155/H.R. 889 (Foreign Cultural Exchange Jurisdictional Immunity Clarification Act); to amend chapter 97 of title 28, United States Code, to clarify the exception to foreign sovereign immunity set forth in section 1605(a)(3) of such title) S. 2763/H.R. 6130 (Holocaust Expropriated Art Recovery Act of 2016); to provide the victims of Holocaust-era persecution and their heirs a fair opportunity to recover works of art confiscated or misappropriated by the Nazis.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses.

General lobbying with regard to proposed revisions to the Federal Rules of Civil Procedure and Federal Rules of Evidence. General lobbying with regard to clarifying state and federal court jurisdiction in certain cases. General lobbying with regard to altering the requirement of complete diversity. S. 401/H.R. 758 (Lawsuit Abuse Reduction Act of 2015); amends Rule 11 of the Federal Rules of Civil Procedure to make sanctions mandatory. Lobbying with regard to federal judicial selection generally, including the Supreme Court of the United States, and with specific regard to the Supreme Court nomination of Judge Merrick Garland. H.R. 2304 (SPEAK FREE Act of 2015); Amends the federal judicial code to allow a person against whom a lawsuit is asserted to file a special motion to dismiss claims referred to as strategic lawsuits against public participation ("SLAPP suits") that arise from an oral or written statement or other expression, or conduct in furtherance of such expression, by the defendant in connection with an official proceeding or about a matter of public concern. H.R. 5111 (Consumer Review Fairness Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services offered in interstate commerce that were the subject of the contract. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits the use of certain clauses in form contracts that restrict the ability of a consumer to communicate regarding the goods or services that were the subject of the contract. H.R. 384/H.R. 3279 (Open Book on Equal Access to Justice Act); amends titles 5 and 28, United States Code, to require annual reports to Congress on, and the maintenance of databases on, awards of fees and other expenses to prevailing parties in certain administrative proceedings and court cases to which the United States is a party. H.R. 2336/S.__ (Sunshine in Litigation Act); amends Chapter 111 of Title 28, United States Code, relating to protective orders, sealing of cases, disclosures of discovery information in civil actions, and for other purposes. H.R. 2110/S. 2044 (Consumer Review Freedom Act); prohibits contracts that prohibit consumers from making certain public comments on businesses. General lobbying with regard to regulatory reform issues. H.R. 185 (Regulatory Accountability Act of 2015); amends the Administrative Procedures Act (APA), which is the law that governs how federal agencies propose and establish regulations. S. 226/ H.R. 427 (REINS Act); provides that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law. S. 543/H.R. 1029 (EPA Science Advisory Board Reform Act of 2015); amends the Environmental Research, Development, and Demonstration Authorization Act of 1978 to revise the process of selecting members of the Science Advisory Board, guidelines for participation in Board advisory activities, and terms of office. H.R. 1927 (Fairness in Class Action Litigation Act of 2015); amends the federal judicial code to prohibit federal courts from certifying any proposed class unless the party seeking to maintain a class action affirmatively demonstrates through admissible evidentiary proof that each proposed class member suffered an injury of the same type and extent as the injury of the named class representatives. S. 1113; amends title 28, United States Code, to remand certain civil actions transferred by the judicial panel on multidistrict litigation. H.R. 1579 (ALERT Act of 2015); amends title 5, united States Code, to provide for the publication, by the Office of Information and Regulatory Affairs, of information relating to rulemakings H.R. 2648/S. 1109 (Truth in Settlements Act of 2015); requires adequate information regarding the tax treatment of payments under settlement agreements entered into by Federal agencies. General lobbying with regard to settlement disclosures. S. 1607 (Independent Agency Regulatory Analysis Act of 2015); authorizes the President to require an independent regulatory agency to: (1) comply, to the extent permitted by law, with regulatory analysis requirements applicable to other federal agencies; (2) publish and provide the Office of Information and Regulatory Affairs with an assessment of the costs and benefits of a proposed or final economically significant rule and an assessment of costs and benefits of alternatives to the rule; and (3) submit to the Office for review any proposed or final economically significant rule. S. 708 (Regulatory Improvement Act of 2015); Requires the Commission to evaluate and make recommendations and propose legislation for modification, consolidation, or repeal of regulations that have been finalized not later than 10 years before the establishment of the Commission (covered regulations) for the purpose of reducing compliance costs, encouraging growth and innovation, improving competitiveness, and protecting public safety. S. 1820 (Early Participation in Regulations Act); requires agencies to publish an advance notice of proposed rule making for major rules. S. 1818 (Principled Rulemaking Act); amends title 5, United States Code, to reform the rule making process of agencies. S. 1817 (Smarter Regs Act of 2015); implements retrospective review of major rules. H.R. 3624 (Fraudulent Joinder Prevention Act of 2015); amends title 28, United States Code, to prevent fraudulent joinder. Lobbying with regard to factoring and structured settlements. H.R. 712 (Sunshine for Regulatory Decrees and Settlements Act); creates new requirements for civil actions seeking to compel agency actions. H.R. 1155 (SCRUB Act); creates new requirements for agencies when making a new rule, creates a regulatory oversight commission. S. 2006 (Regulatory Accountability Act of 2015); reforms the process by which Federal agencies analyze and formulate new regulations and guidance documents. H.R. 4768 (Separation of Powers Restoration Act); modifies the scope of judicial review of agency actions to authorize courts reviewing agency actions to decide de novo all relevant questions of law, including the interpretation of constitutional and statutory provisions and rules. H.R. 4612 (Midnight Rule Relief Act of 2016); prohibits some federal agencies from proposing or finalizing any midnight rule unless the Office of Information and Regulatory Affairs finds that such a rule will not result in: (1) an annual effect on the economy of $100 million or more; (2) a major increase in costs or prices; (3) significant adverse effects on competition, employment, investment, productivity, innovation, or the ability of U.S.-based enterprises to compete internationally; or (4) a significant economic impact on a substantial number of small businesses. H.R. 5063 (Stop Settlement Slush Funds Act of 2016); prohibits government officials from entering into a settlement agreement resolving a civil action on behalf of the United States, or from enforcing such a settlement agreement, if that agreement requires a donation to be made to any person by any party (other than the United States) to such agreement. S. 3446/H.R. 3765 (ADA Education and Reform Act of 2015); amends the Americans with Disabilities Act of 1990 to promote compliance through education, to clarify the requirements for demand letters, to provide for a notice and cure period before the commencement of a private civil action. H.R. 241 (ADA Compliance for Customer Entry to Stores and Services (ACCESS) Act of 2015); amends the Americans with Disabilities Act of 1990 to prohibit an aggrieved person from commencing a civil action for discrimination based on the failure to remove a structural barrier to entry into an existing public accommodation unless the owner or operator of such accommodation: (1) is provided a written notice specific enough to identify such barrier; and (2) has, within specified time periods, either failed to provide the aggrieved person with a written description outlining improvements that will be made to remove such barrier or provided such description and failed to remove such barrier. H.R. 4719 (Correcting Obstructions to Mediate, Prevent, and Limit Inaccessibility (COMPLI) Act); amends the Americans with Disabilities Act of 1990 to prohibit persons aggrieved by certain public accommodation violations from commencing a civil action for discrimination unless they: (1) provide the owner or operator of the accommodation with a written notice that is specific enough to identify the violation; (2) specify in the notice that the owner or operator has 90 days to remove or correct the violation before an action will be brought; and (3) refrain from sending demand letters, requests for settlement, or other communications to the owner or operator during such 90-day period. General lobbying with respect to diversity jurisdiction and potential changes to the jurisdiction rules. S. 3155/H.R. 889 (Foreign Cultural Exchange Jurisdictional Immunity Clarification Act); to amend chapter 97 of title 28, United States Code, to clarify the exception to foreign sovereign immunity set forth in section 1605(a)(3) of such title) S. 2763/H.R. 6130 (Holocaust Expropriated Art Recovery Act of 2016); to provide the victims of Holocaust-era persecution and their heirs a fair opportunity to recover works of art confiscated or misappropriated by the Nazis.